BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27897452)

  • 1. Characterization of two recombinant HVT-IBD vaccines by VP2 insert detection and cell-mediated immunity after vaccination of specific pathogen-free chickens.
    Ingrao F; Rauw F; van den Berg T; Lambrecht B
    Avian Pathol; 2017 Jun; 46(3):289-299. PubMed ID: 27897452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Recombinant HVT-IBD Vaccines Administered to Broiler Chicks from a Single Breeder Flock at 30 and 60 Weeks of Age.
    Gelb J; Jackwood DJ; Brannick EM; Ladman BS
    Avian Dis; 2016 Sep; 60(3):603-12. PubMed ID: 27610719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified live infectious bursal disease virus (IBDV) vaccine delays infection of neonatal broiler chickens with variant IBDV compared to turkey herpesvirus (HVT)-IBDV vectored vaccine.
    Kurukulasuriya S; Ahmed KA; Ojkic D; Gunawardana T; Goonewardene K; Gupta A; Chow-Lockerbie B; Popowich S; Willson P; Tikoo SK; Gomis S
    Vaccine; 2017 Feb; 35(6):882-888. PubMed ID: 28089549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete, long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens.
    Tsukamoto K; Saito S; Saeki S; Sato T; Tanimura N; Isobe T; Mase M; Imada T; Yuasa N; Yamaguchi S
    J Virol; 2002 Jun; 76(11):5637-45. PubMed ID: 11991992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine.
    Andoh K; Yamazaki K; Honda Y; Honda T
    Arch Virol; 2017 Apr; 162(4):931-941. PubMed ID: 27942974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a novel in ovo-attenuated live vaccine and recombinant vaccine against a very virulent infectious bursal disease virus in chickens.
    Okura T; Otomo H; Suzuki S; Ono Y; Taneno A; Oishi E
    J Vet Med Sci; 2021 Oct; 83(11):1686-1693. PubMed ID: 34526420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses.
    van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I
    Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale manufacture and use of recombinant VP2 vaccine against infectious bursal disease in chickens.
    Rong J; Jiang T; Cheng T; Shen M; Du Y; Li S; Wang S; Xu B; Fan G
    Vaccine; 2007 Nov; 25(46):7900-8. PubMed ID: 17923174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens.
    Pradhan SN; Prince PR; Madhumathi J; Roy P; Narayanan RB; Antony U
    Vet Immunol Immunopathol; 2012 Aug; 148(3-4):293-301. PubMed ID: 22795186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses upon in ovo HVT-IBD vaccination vary between different chicken lines.
    Dobner M; Auerbach M; Mundt E; Preisinger R; Icken W; Rautenschlein S
    Dev Comp Immunol; 2019 Nov; 100():103422. PubMed ID: 31247248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early immune responses and profiling of cell-mediated immunity-associated gene expression in response to rHVT-IBD vaccination.
    Ingrao F; Rauw F; Steensels M; van den Berg T; Lambrecht B
    Vaccine; 2018 Jan; 36(5):615-623. PubMed ID: 29290477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of infectious bursal disease live vaccines and a HVT-IBD vector vaccine and their effects on the immune system of commercial layer pullets.
    Prandini F; Simon B; Jung A; Pöppel M; Lemiere S; Rautenschlein S
    Avian Pathol; 2016; 45(1):114-25. PubMed ID: 26743805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective oral vaccination against infectious bursal disease virus using the major viral antigenic protein VP2 produced in Pichia pastoris.
    Taghavian O; Spiegel H; Hauck R; Hafez HM; Fischer R; Schillberg S
    PLoS One; 2013; 8(12):e83210. PubMed ID: 24376665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baculovirus virions displaying infectious bursal disease virus VP2 protein protect chickens against infectious bursal disease virus infection.
    Xu XG; Tong DW; Wang ZS; Zhang Q; Li ZC; Zhang K; Li W; Liu HJ
    Avian Dis; 2011 Jun; 55(2):223-9. PubMed ID: 21793437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens.
    Rong J; Cheng T; Liu X; Jiang T; Gu H; Zou G
    Vaccine; 2005 Sep; 23(40):4844-51. PubMed ID: 15979770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virus.
    Wang W; Song Y; Liu L; Zhang Y; Wang T; Zhang W; Li K; Qi X; Gao Y; Gao L; Liu C; Zhang Y; Wang Y; Pan Q; He G; Wang X; Cui H
    Microb Cell Fact; 2019 Jan; 18(1):21. PubMed ID: 30704494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against very virulent infectious bursal disease virus in chickens immunized with DNA vaccines.
    Kim SJ; Sung HW; Han JH; Jackwood D; Kwon HM
    Vet Microbiol; 2004 Jun; 101(1):39-51. PubMed ID: 15201032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A recombinant turkey herpesvirus expressing chicken interleukin-2 increases the protection provided by in ovo vaccination with infectious bursal disease and infectious bronchitis virus.
    Tarpey I; van Loon AA; de Haas N; Davis PJ; Orbell S; Cavanagh D; Britton P; Casais R; Sondermeijer P; Sundick R
    Vaccine; 2007 Dec; 25(51):8529-35. PubMed ID: 17996994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of a novel recombinant Marek's disease virus vector vaccine against infectious bursal disease in chickens with or without maternal antibodies.
    Li K; Liu Y; Zhang Y; Gao L; Liu C; Cui H; Qi X; Gao Y; Zhong L; Wang X
    Vet Immunol Immunopathol; 2017 Apr; 186():55-59. PubMed ID: 28413051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens.
    Francois A; Chevalier C; Delmas B; Eterradossi N; Toquin D; Rivallan G; Langlois P
    Vaccine; 2004 Jun; 22(17-18):2351-60. PubMed ID: 15149796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.